Kyle Rose
Stock Analyst at Canaccord Genuity
(3.24)
# 1,055
Out of 4,732 analysts
118
Total ratings
51.55%
Success rate
11.85%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FNA Paragon 28 | Maintains: Buy | $17 → $15 | $10.88 | +37.87% | 7 | Nov 13, 2024 | |
| SYK Stryker | Maintains: Buy | $360 → $400 | $383.42 | +4.32% | 19 | Oct 30, 2024 | |
| PODD Insulet | Maintains: Buy | $226 → $234 | $275.81 | -15.16% | 15 | May 10, 2024 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $90.80 | -21.81% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $46.63 | +52.26% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $16.79 | +31.03% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.74 | +474.71% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $11.57 | +90.15% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $84.38 | +77.77% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $15.85 | +1,603.47% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $16.69 | +61.77% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.69 | +457.62% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $18.09 | -17.08% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $149.11 | -18.18% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $4.09 | -2.20% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $10.04 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $109.56 | +14.09% | 7 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $55 | $25.29 | +117.48% | 5 | Apr 30, 2021 |
Paragon 28
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $10.88
Upside: +37.87%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $383.42
Upside: +4.32%
Insulet
May 10, 2024
Maintains: Buy
Price Target: $226 → $234
Current: $275.81
Upside: -15.16%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $90.80
Upside: -21.81%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $46.63
Upside: +52.26%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $16.79
Upside: +31.03%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.74
Upside: +474.71%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $11.57
Upside: +90.15%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $84.38
Upside: +77.77%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $15.85
Upside: +1,603.47%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $16.69
Upside: +61.77%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $2.69
Upside: +457.62%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $18.09
Upside: -17.08%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $149.11
Upside: -18.18%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $4.09
Upside: -2.20%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $10.04
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $109.56
Upside: +14.09%
Apr 30, 2021
Maintains: Buy
Price Target: $53 → $55
Current: $25.29
Upside: +117.48%